Novel tetrahydropyran-based peptidomimetics from a bioisosteric transformation of a tripeptide. Evidence of their activity at melanocortin receptors

被引:12
作者
Mazur, AW [1 ]
Kulesza, A [1 ]
Mishra, RK [1 ]
Cross-Doersen, D [1 ]
Russell, AF [1 ]
Ebetino, FH [1 ]
机构
[1] Procter & Gamble Pharmaceut, Hlth Care Res Ctr, Mason, OH 45040 USA
关键词
D O I
10.1016/S0968-0896(03)00274-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have prepared novel peptidomimetics based on a 2,4,6-trisubstituted tetrahydropyran. This scaffold was constructed in an isosteric transformation using conceptual constraints imposed on a tripeptide moiety involving O-i'-C-1(+1)gamma and O-i'-Ni+2 formal cyclization modes. A series of regioselective transformations commencing with a substituted dihydropyran-4-one readily provided the required analogues. Specific tetrahydropyrane analogues modeled on PheArgTrp as a truncated version of the melanocortin receptor message sequence, showed activity at the melanocortin receptors MC4R and MC1R. Thus, the 2,4,6-trisubstituted tetrahydropyran scaffold has provided a potentially useful peptidomimetic lead, and conceptual cyclization of peptide moieties can offer a valuable design strategy in peptidomimetic research. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3053 / 3063
页数:11
相关论文
共 34 条
[11]   Homologs of 1,2,5-hexahydro-3-one-1H-1,4-diazepine (DAP) as novel dipeptidomimetics and molecular scaffolds:: Efficient preparation of synthons [J].
Han, YL ;
Mierke, DF ;
Chorev, M .
BIOPOLYMERS, 2002, 64 (01) :1-15
[12]   Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R [J].
HaskellLuevano, C ;
Hendrata, S ;
North, C ;
Sawyer, TK ;
Hadley, ME ;
Hruby, VJ ;
Dickinson, C ;
Gantz, I .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (14) :2133-2139
[13]   NONPEPTIDAL PEPTIDOMIMETICS WITH A BETA-D-GLUCOSE SCAFFOLDING - A PARTIAL SOMATOSTATIN AGONIST BEARING A CLOSE STRUCTURAL RELATIONSHIP TO A POTENT, SELECTIVE SUBSTANCE-P ANTAGONIST [J].
HIRSCHMANN, R ;
NICOLAOU, KC ;
PIETRANICO, S ;
SALVINO, J ;
LEAHY, EM ;
SPRENGELER, PA ;
FURST, G ;
SMITH, AB ;
STRADER, CD ;
CASCIERI, MA ;
CANDELORE, MR ;
DONALDSON, C ;
VALE, W ;
MAECHLER, L .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (23) :9217-9218
[14]   Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors.: 4.: Modifications at the Trp position [J].
Holder, JR ;
Xiang, ZM ;
Bauzo, RM ;
Haskell-Leuvano, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (26) :5736-5744
[15]   Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads [J].
Hruby, VJ ;
Balse, PM .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (09) :945-970
[16]  
HUDLICKY M, 1996, ACS MONOGR SER, V188, P298
[17]   IMPROVED METHOD FOR THE PREPARATION OF GUANIDINES [J].
KIM, KS ;
QIAN, LG .
TETRAHEDRON LETTERS, 1993, 34 (48) :7677-7680
[18]   SYNTHESIS OF HYDROXYETHYLENE ISOSTERES OF THE TRANSITION-STATE OF THE HIV PROTEASE-CATALYZED PHE-PRO HYDROLYSIS - REACTION OF 2-[(BOC)AMINO]-1-(2'-OXOCYCLOPENTYL)-3-PHENYLPROPANOLS WITH DIETHYL PHOSPHOROCYANIDATE AND LITHIUM CYANIDE FOLLOWED BY SAMARIUM IODIDE [J].
KONIECZNY, MT ;
TOMA, PH ;
CUSHMAN, M .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (17) :4619-4624
[19]  
Le Merrer Y, 1999, METH MOLEC MED, V23, P227, DOI 10.1385/0-89603-517-4:227
[20]  
Lohof E, 1999, ADV AMIN AC MIM PEPT, V2, P263, DOI 10.1016/S1874-5113(99)80011-2